MedElevator
Войти в исследования Scandinavian journal of gastroenterology · 2010
Pancreatic function and morphology in Sjögren's syndrome.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Afzelius Pia, Fallentin Eva Marie, Larsen Steen, Møller Søren, Schiødt Morten
Аннотация
OBJECTIVE: Sjögren's syndrome (SS) is considered to be a universal exocrinopathy most likely based on autoimmune mechanisms. The degree of exocrine involvement in SS with the exception of salivary and lachrymal glands is, however, not yet established.
MATERIAL AND METHODS: We therefore examined the morphology, the exocrine and endocrine functions of the pancreas in 12 healthy consecutively included levolunteers with established SS, but without known pancreatic disease, using secretin-stimulated magnetic resonance cholangiopancreatography (MRCP), a Lundh test, oral glucose tolerance test, and blood sampling.
RESULTS: Twenty-five percent of the patients had morphological changes of pancreas as evaluated by secretin-stimulated MRCP, and two patients had chronic pancreatitis-like changes. Four patients had reduced exocrine function of the pancreas with either significantly reduced amylase and/or lipase in the pancreatic juice.
CONCLUSIONS: The prevalence of pancreatic dysfunction was increased to 25-33% in the study population which is much higher than in the background population. Thus, pancreatic dysfunction and chronic pancreatitis should be considered in SS.
MATERIAL AND METHODS: We therefore examined the morphology, the exocrine and endocrine functions of the pancreas in 12 healthy consecutively included levolunteers with established SS, but without known pancreatic disease, using secretin-stimulated magnetic resonance cholangiopancreatography (MRCP), a Lundh test, oral glucose tolerance test, and blood sampling.
RESULTS: Twenty-five percent of the patients had morphological changes of pancreas as evaluated by secretin-stimulated MRCP, and two patients had chronic pancreatitis-like changes. Four patients had reduced exocrine function of the pancreas with either significantly reduced amylase and/or lipase in the pancreatic juice.
CONCLUSIONS: The prevalence of pancreatic dysfunction was increased to 25-33% in the study population which is much higher than in the background population. Thus, pancreatic dysfunction and chronic pancreatitis should be considered in SS.